Distributed by

BRISTOL-MYERS SQUIBB PHARMA (THAILAND) LTD

Featured products of Bristol-Myers Squibb

Opdivo

Opdivo soln for infusion 100 mg/10 mL

nivolumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF01 - nivolumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Opdivo soln for infusion 40 mg/4 mL

nivolumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF01 - nivolumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Yervoy

Yervoy infusion 50 mg/10 mL

ipilimumab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX04 - ipilimumab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Distributed by DKSH

Opdivo

Opdivo soln for infusion 100 mg/10 mL

nivolumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF01 - nivolumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Opdivo soln for infusion 40 mg/4 mL

nivolumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF01 - nivolumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Yervoy

Yervoy infusion 50 mg/10 mL

ipilimumab

Packing/Price

1's

MIMS Class

Cancer Immunotherapy

ATC Classification

L01FX04 - ipilimumab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.